(Natural News)—Numerous laboratory studies have confirmed the presence of plasmid DNA in Pfizer’s COVID-19 vaccines. In fact, a recent analysis reveals that a single dose of the Pfizer vaccine can contain over 200 billion DNA fragments. These are nucleotides that should never enter the human supply chain because they can cause cancer.
Plasmids, which are used in the manufacturing process for vaccines, carry genetic material that can inadvertently enter the human body through vaccination. Plasmids can disrupt cellular functions or contribute to the development of antibiotic resistance. These fragments have the potential to integrate into the DNA of vaccinated individuals, potentially disrupting the function of oncogenes and tumor suppressor genes. One troubling aspect is the inclusion of sequences from the SV40 virus, known for its cancer-causing properties. The implications of such contamination are dire, with experts warning of the potential for permanent genetic changes in vaccine recipients.
This serious safety concern necessitates that ALL recombinant vaccines be investigated for DNA contamination. The current findings on DNA contamination across the vaccine supply are startling, and warrant an audit into the manufacturing processes of vaccines, including investigations into the role adjuvants and lipid nanoparticles play in facilitating the DNA contamination of human cells.
Australia taking DNA contamination of COVID vaccines seriously now
The Port Hedland council in Australia recently passed a motion recognizing “unacceptable levels of plasmid DNA contamination” in mRNA COVID vaccines. The motion, which also mandated the dissemination of this information to health practitioners and vaccine recipients, represents a significant shift in how vaccine safety concerns are addressed. Given Port Hedland’s economic significance in Australia, this council’s decision is likely to have far-reaching implications. For the first time, health practitioners are being formally alerted to the dangers posed by plasmid contamination — a topic that has been heavily suppressed since the #plasmidgate controversy surfaced in early 2023.
Adjuvants in Gardasil vaccine may facilitate plasmids into teenagers
Compounding the controversy is a recent exposé written by investigative journalist Maryanne Demasi. The exposé reveals similar issues with the Gardasil HPV vaccine. The report highlights the FDA’s awareness of residual plasmid DNA in Gardasil, a contamination concern that dates back to 2011. This is an issue that has been blacklisted from vaccine safety discussions in the media and between government regulators.
This DNA contamination is made more dangerous due to the use of adjuvants in vaccines. The adjuvant is added to vaccines to enhance the immune response. One of the most common adjuvants – aluminum salts – technically act as a transfection agent, allowing foreign DNA to enter the cytoplasm of human immune cells, which then circulate throughout the body. The implications of this toxic facilitation are profound; the introduction of lab-derived plasmids into the human body poses significant risks, including the potential for cancer and other genetic diseases.
Antigen levels and body weight/blood volume of vaccine recipient are important factors
COVID-19 vaccines use lipid nanoparticles which facilitate the entry of plasmid DNA into human cells. The Novavax vaccine contains a saponin adjuvant that has similar risks as the lipid nanoparticles. A Hepatitis B vaccine (Engerix-B), used in newborn babies, contains both aluminum hydroxide and polysorbate 20. These ingredients act as transfection agents, potentially facilitating plasmids into the baby and setting the stage for childhood cancer.
Moreover, a greater quantity of antigen has a greater chance of introducing plasmids into human cells. Conversely, the DNA contamination could have more pronounced effects on babies with a lower blood volume and body weight. The Engerix vaccine (injected into babies) contains 20 micrograms of antigen, whereas the Gardasil HPV vaccine (injected into teenagers) contains 270 micrograms. The dosage of the antigen is important, as well as the blood volume and weight of the person being injected.
The HPV vaccine contains 13 times more foreign proteins and DNA than the Hep B vaccines. Essentially, the HPV vaccines is equivalent to 13 injections of the Hep vaccine, in terms of antigen quantity. Still, the Hep B vaccine is given to infants, not teenagers, and therefore introduces a disproportionate level of contamination to a baby with lower blood volume and body weight. Both vaccines pose serious DNA contamination risks on two different ends of the exposure spectrum.
All vaccines utilize a risky transfection process using adjuvants
Essential to the function of a vaccine is the term “transfection.” This process allows foreign genetic material to enter human cells — a mechanism that typically doesn’t occur naturally. Human cells possess protective barriers that prevent the uptake of foreign nucleic acids. However, laboratory techniques have been developed to bypass these defenses. The main methods of transfection include:
- Mechanical Disruption: Physically puncturing the cell membrane to allow DNA entry
- Chemical Facilitation: Utilizing chemicals that mimic essential cellular components, acting like a Trojan horse to transport DNA into the cell
- Electroporation: Applying an electric field to create temporary pores in the cell membrane, though this method is less practical for widespread human use
Among these, chemical agents are the most viable for introducing nucleic acids into cells. Commonly used transfection agents include cationic particles, which are positively charged and attract the negatively charged components of cell membranes. Detergents can also disrupt membranes, enabling the entry of nucleic acids. The concern surrounding the use of lab-reagent plasmids is significant. These plasmids can contain nucleotides that may lead to severe genetic consequences, including cancer, if transferred into human cells. When a transfection agent is present, the likelihood of this transfer increases substantially.
While many are familiar with standard transfection agents like lipids (lipofectamine, lipid nanoparticles) and calcium phosphate, a broader range of substances can act as transfection agents. Here are some less commonly recognized ones:
- Polysorbate: A surfactant/emulsifier that can enhance transfection
- Metallic Cations: Elements such as aluminum, zirconium, and cerium, known for their positive charge and transfection efficiency
- Saponins: Soaps used as adjuvants in certain vaccines, promoting transfection
- Histidine: A positively charged amino acid that can aid in the transfection process
Understanding the toxicity potential of these transfection agents is crucial, especially in light of their implications for causing cancer in children, teenagers, and adults.
Sources include:
- NaturalNews.com
- ArkMedic.info [1]
- ArkMedic.info [2]
- Blog.MaryAnneDemasi.substack.com
- Public4PageFreezer.com
Bypass Big Tech Censors
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.
